Associate Professor Branka Grubor-Bauk, Professor Eric Gowans and their Viral Immunology Group at the BHI, TQEH are leading a new COVID-19 vaccine trial that targets the Omicron variant. Participants over the age of 18 who were triple-vaccinated over three months ago, and who have not had COVID-19, may be eligible to participate: https://health.adelaide.edu.au/cosvac-study.
